Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EG.5.1.17ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.5.1.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.1.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.1.17NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.1.10ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.1.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.1.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.1.10NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.3.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.3.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.3.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.3.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XDDORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XDDENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDDENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDDNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.53ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.53ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.53ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.53NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.60ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.60ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.60ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.60NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.6.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.6.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.6.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.6.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.28ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.28ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.28NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
P.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
P.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
P.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
P.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-6672.85US
P.2 (Zeta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
P.2 (Zeta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
P.2 (Zeta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
P.2 (Zeta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.33ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.33ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.33ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.33NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
N.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
N.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
N.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
N.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.499ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.499ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used